Chloroquine Phosphate

Treatment for Malaria

Typical Dosage: Adults: 1000mg salt initially, then 500mg at 6-8 hours, then 500mg daily for 2 more days

Effectiveness
97%
Safety Score
70%
Clinical Trials
131
Participants
500K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
Adults: 1000mg salt initially, then 500mg at 6-8 hours, then 500mg daily for 2 more days
Time to Effect
2-3 days
Treatment Duration
3 days
Evidence Quality
HIGH
Confidence Score
92%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$2
Monitoring:$20
Side Effect Mgmt:$5
Total Annual:$27
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0.08
Outcome-Based Costs
Cost per Responder
$27.8
Cost per Remission
$27.8
Chloroquine Phosphate Outcomes

for Malaria

Efficacy Outcomes
Overall Effectiveness
+97%
Response Rate
+97%
Remission Rate
+97%
Common Side Effects
Pruritus
+50%
Nausea/Vomiting
+20%
Abdominal pain
+10%
Headache
+10%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov

Completed Clinical Trials
16 completed trials for Chloroquine Phosphate in Malaria

Evaluating the Role of Chloroquine for Malaria Elimination

NCT02698748COMPLETEDPHASE2, PHASE3
View Study
75 participants
INTERVENTIONAL
Manhiça, Mozambique
Started: Jan 1, 2015

Effectiveness of Malaria Treatment in Mexico

NCT02394197COMPLETEDPHASE4
View Study
153 participants
INTERVENTIONAL
Started: Feb 1, 2008

Therapeutic Efficacy of Chloroquine Plus Primaquine in the Treatment of Uncomplicated Plasmodium Vivax

NCT06044805COMPLETEDPHASE4
View Study
100 participants
INTERVENTIONAL
Arba Minch, Ethiopia
Started: Dec 19, 2022

Dose Escalation PfSPZ-CVac

NCT03083847COMPLETEDPHASE1
View Study
55 participants
INTERVENTIONAL
Bethesda, United States
Started: Jun 5, 2017

Chloroquine Population Pharmacokinetics in Pre and Post-partum Women

NCT01546961COMPLETEDNA
View Study
49 participants
INTERVENTIONAL
Tak, Thailand
Started: Jun 1, 2011

Sanaria PfSPZ Challenge With Pyrimethamine or Chloroquine Chemoprophylaxis Vaccination (PfSPZ-CVac Approach): A Randomized Double Blind Placebo Controlled Phase I/II Trial to Determine Safety and Protective Efficacy Against Natural Plasmodium Falcipa...

NCT03952650COMPLETEDPHASE1, PHASE2
View Study
252 participants
INTERVENTIONAL
Bamako, Mali
Started: May 23, 2019

G6PD (Glucose-6-phosphate Dehydrogenase) Study to Evaluate Hemolysis Potential of TFQ (Tafenoquine)

NCT01205178COMPLETEDPHASE1
View Study
192 participants
INTERVENTIONAL
Bangkok, Thailand +1 more
Started: Jul 2, 2009

Safety and Efficacy of Different Regimens of Primaquine on Vivax Malaria Treatment in G6PD Deficient Patients

NCT03529396COMPLETEDPHASE2
View Study
106 participants
INTERVENTIONAL
Manaus, Brazil +1 more
Started: Jul 20, 2018

Pharmacokinetic Study of Multi-dose Chloroquine

NCT01814423COMPLETEDPHASE4
View Study
30 participants
INTERVENTIONAL
Bissau, Guinea-Bissau
Started: Apr 1, 2013

Estimating the Risk of Plasmodium Vivax Relapses in Afghanistan

NCT01178021COMPLETEDPHASE4
View Study
593 participants
INTERVENTIONAL
Maymana, Afghanistan +2 more
Started: Aug 1, 2009

TES of Chloroquine for Pv in the Philippines in 2016

NCT05958797COMPLETED
View Study
74 participants
OBSERVATIONAL
Started: Jan 4, 2016

Chloroquine and Post Malaria Anaemia Study

NCT00473837COMPLETEDNA
View Study
96 participants
INTERVENTIONAL
Started: Jul 1, 2007

Chloroquine for Malaria in Pregnancy

NCT01443130COMPLETEDPHASE3
View Study
900 participants
INTERVENTIONAL
Blantryre, Malawi
Started: Feb 1, 2012

Extended-dose Chloroquine (ECQ) for Resistant Falciparum Malaria Among Afghan Refugees in Pakistan

NCT01019408COMPLETEDPHASE4
View Study
163 participants
INTERVENTIONAL
Adezai, Pakistan +2 more
Started: Nov 1, 1993

Study on the Treatment of Vivax Malaria

NCT01074905COMPLETEDPHASE3
View Study
655 participants
INTERVENTIONAL
Mae Sot, Thailand
Started: May 1, 2010

Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Malaria in India

NCT00074841COMPLETEDPHASE2, PHASE3
View Study
230 participants
INTERVENTIONAL
Dispur Guwahati, India +6 more
Started: Sep 1, 2003
Showing 20 of 131 total trials